Alfred Clinical Trials

Alfred Health has more than 700 open trials across 20 clinical disciplines, our clinical trial portfolio is one of the largest in the country.

Clear filter
604 clinical trials found
Clinical trials

SNAP

Staphylococcus aureus Network Adaptive Platform trial (SNAP) (NCT05137119)

Currently recruiting

SNIPER

Stereotactic ablative body radiation therapy with Nodal Irradiation for ProstatE canceR (ACTRN12625000259448)

Currently recruiting

SALSA

Stopping Antiviral Therapy in People with HBeAg-negative CHB and Low Surface Antigen (Trial Not Registered)

Currently recruiting

STAR AF

STRATEGIES FOR CATHETER ABLATION OF PERSISTENT ATRIAL FIBRILLATION: A RANDOMIZED, COMPARATIVE STUDY (STAR AF 3) (NCT04428944)

Currently recruiting

M23-324

Study M23-324: A First-in-Human Study of ABBV-525 (MALT1 Inhibitor) in B-Cell Malignancies (NCT05618028)

Currently recruiting

STOPit

Study of tofacitinib for the treatment of chronic pouchitis (STOPit) (ACTRN12621000173897)

Currently recruiting

CAST BM12

Study of using Cyclophosphamide After Sibling-donor allogeneic stem-cell Transplantation (CAST) in patients with acute leukaemia and myelodysplasia: a randomised study comparing cyclosporin and methotrexate to cyclosporin and post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis (ACTRN12618000505202)

Currently recruiting

SEAFARER

Subscalp EEG Augmentation For Accuracy and Reliability in Epilepsy Reviews (ACTRN12625000231448)

Currently recruiting

SNaPP Study

Sugammadex, neostigmine and postoperative pulmonary complications (the SNaPP Study) (ACTRN12623000394640)

Currently recruiting

SunSmart in ACEMID

SunSmart in ACEMID Pilot study (Trial Not Registered)

Currently recruiting

DISCUS

Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease: a randomised controlled trial - DISCUS-IBD (ACTRN12622001458729)

Currently recruiting

SISS

Switching patients from intravenous to subcutaneous infliximab in inflammatory bowel disease (ACTRN12621001498886)

Currently recruiting

SWIFT

Symptom monitoring WIth Feedback Trial (SWIFT) (ACTRN12620001061921)

Coming soon

DB in asthma

Targeted treatment for people with dysfunctional breathing and difficult asthma (ACTRN12624001285549)

Currently recruiting

The Alison Project

The Alison Project: A randomised double-blind placebo controlled investigation of adjunctive memantine in the treatment of symptoms of complex trauma disorder (also known as borderline personality disorder) (NCT02097706)

Currently recruiting

DEFINE

The effect of substantial weight loss with tirzepatide on heart failure with preserved ejection fraction in people with obesity (ACTRN12624000270516)

Coming soon

PREGMOL

The immunobiology of pregnancy, and impacts inwomen with Multiple Sclerosis (MS) or Neuromyelitis Optica Spectrum Disorder(NMOSD) (ACTRN12623000951651)

Recently completed/closed

ICE EXAPANCE

The Intelligent Computerized Engine (ICE) Aspiration System Clinical Study: First In Human

Recently completed/closed

AML M22 PLATFORM

The International Acute myeloid leukaemia (AML) Platform Consortium (IAPC) trial is a randomised, multi-arm study platform to compare the efficacy of experimental therapies versus standard of care in subjects with acute myeloid leukaemia in first complete remission. Domain 2 is investigating the safety and efficacy of Venetoclax as a maintenance therapy alone or in combination with low dose cytarabine (LDAC) (ACTRN12619000280101)

Currently recruiting

Keto eCoach

The Keto eCoach Program: a multimodality digital health intervention to aid the delivery of ketogenic diet therapy for epilepsy (ACTRN12624000486527)

Currently recruiting
27 28 29 30 31